#China #Beijing #Eyebright Medical #Loong Crystal PR #Intraocular Lens

Eyebright Medical Achieves Groundbreaking Certification

Eyebright Medical Technology (Beijing) Co., Ltd. has made a significant advancement in ophthalmology by announcing that its innovative phakic intraocular lens, named the "Loong Crystal PR," has officially received the National Medical Products Administration (NMPA) Class III certification in China. This certification is a pivotal milestone for Eyebright Medical, showcasing the company's commitment to pioneering solutions in vision correction and eye health.

Advanced Design for Optimal Vision Correction

The Loong Crystal PR lens is expertly crafted for adult patients who require effective myopia correction. It can accommodate a range of myopia spanning from -3.25 D to -18.00 D. This flexibility ensures that the lens can be tailored to meet the individual visual needs of patients, promoting better visual outcomes and enhancing patient satisfaction.

The design features of the Loong Crystal PR are impressive. It is made using advanced balanced acrylic material, which significantly contributes to its optical performance. The lens incorporates a zero spherical aberration design that features a broad optical zone, alongside a stable dual-concave arc height structure. This innovative implantation enables the lens to act as a refractive element that boosts visual acuity post-surgery, offering patients high-quality outcomes and an improved overall visual experience.

A Commitment to Innovation and Quality

Eyebright Medical has always prioritized innovation and technology, seeking to deliver safe, reliable, and high-quality ophthalmic solutions. The company dedicates significant resources to ongoing research and development, ensuring that it stays at the forefront of the ophthalmic industry. By advancing its product offerings, Eyebright Medical is committed to enhancing the recognition of domestic brands within China’s healthcare sector.

About Eyebright Medical

Established in Beijing, Eyebright Medical Technology (Beijing) Ltd. has positioned itself as a high-tech enterprise acknowledged at the state level. With its stock code being 688050.SH, the company has emerged as a leader in the medical device manufacturing sphere, particularly in ophthalmology.

The product portfolio of Eyebright Medical encompasses three main areas: cataract surgery, myopia treatment, and consumer vision care. The organization has strategically broadened its product line to provide comprehensive ocular health solutions, thereby addressing the entire lifecycle of eye care. The overarching goal of Eyebright Medical is to transition into a globally recognized leader in the medical field, capitalizing on the strengths of China's intelligent manufacturing capabilities.

For more information about Eyebright Medical and its products, please visit their official website at Eyebright Medical.

• ---